1.66

0.61% +0.03

AEON Biopharma Inc. (AEON)

Overview News Price History Discussions Forecast

AEON Biopharma Inc. stock is currently priced at $1.66, with a 24-hour trading volume of 49,703. It has seen a +0.61% increased in the last 24 hours and a -80.48% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.69 pivot point. If it approaches the $1.57 support level, significant changes may occur.

Previous Close:

$1.63

Open:

$1.69

24h Volume:

49,703

Market Cap:

$63.22M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-57.40%

1M Performance:

-80.48%

6M Performance:

-64.50%

1Y Performance:

+0.00%

1D Range:

$1.5201

$1.69

52W Range:

$1.38

$17.17

AEON Biopharma Inc. Stock (AEON) Company Profile

Name

AEON Biopharma Inc.

Sector

Healthcare (1219)

Industry

Biotechnology (700)

Phone

(949) 354-6499

Address

5 Park Plaza, Suite 1750, Irvine

Employee

Twitter

Next Earnings Date

Latest SEC Filings

AEON's Discussions on Twitter

AEON Biopharma Inc. Stock (AEON) Latest News

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine

GlobeNewswire Inc.

AEON Biopharma Inc. Stock (AEON) Financials Data

There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.